ArticleCureus2026
Chikungunya-Associated Acute Respiratory Distress Syndrome: A Rare Fatal Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chikungunya fever is an arboviral disease caused by an alphavirus belonging to the family Togaviridae. It commonly presents with fever, severe arthralgia, rash, and myalgia, while severe pulmonary involvement causing acute respiratory distress syndrome (ARDS) is rare. We report a 62-year-old man with obesity, diabetes mellitus, hypertension, obstructive sleep apnoea, coronary artery disease, and interstitial lung disease, who presented with high-grade fever, severe arthralgia, facial puffiness, and rapidly progressive dyspnoea, following recent travel to Lucknow, India. On admission, he had severe hypoxemia with a PaO₂/FiO₂ ratio below 100, requiring mechanical ventilation. During intubation, he developed cardiac arrest but achieved return of spontaneous circulation after cardiopulmonary resuscitation. Chikungunya IgM and reverse transcriptase polymerase chain reaction (RT-PCR) were positive. Chest imaging showed diffuse bilateral infiltrates and ground-glass opacities consistent with severe ARDS. Dengue, malaria, and scrub typhus were excluded. The patient was managed with lung-protective ventilation, prone positioning, and corticosteroids according to the Meduri protocol with transient improvement. However, he later developed worsening respiratory failure and multiorgan dysfunction and eventually succumbed after 41 days of hospitalization. Although chikungunya is not typically considered a respiratory virus, clinicians should recognize that severe pulmonary manifestations, including ARDS, may occur, particularly in elderly patients with significant comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.